Pseudovax

DRUG2 trials

Sponsors

Oslo University Hospital HF, Oslo University Hospital

Conditions

Pseudomyxoma Peritonei

Early Phase 1

Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei

RecruitingNCT07341360

Oslo University HospitalPseudomyxoma Peritonei

Start: 2025-10-13End: 2034-12-31Target: 10Updated: 2026-01-14

Phase 1

PSEUDOVAX – A CANCER VACCINE TARGETING MUTATED GNAS COMBINED WITH IMMUNE CHECKPOINT INHIBITION FOR PATIENTS WITH PSEUDOMYXOMA PERITONEI

RecruitingCTIS2024-517047-30-01

Oslo University Hospital HFPseudomyxoma Peritonei

Start: 2025-09-01Target: 10Updated: 2025-09-01